The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes
Open accessAbstract
Bile acids (BAs), the end products of cholesterol catabolism, are essential for the absorption of lipids and fat-soluble vitamins; but they have also emerged as novel signaling molecules that act as metabolic regulators. It has been well described that the enterohe-patic circulation, a nuclear (FXR) and a cytoplasmic (TGR5/M-BAR) receptor aid in controlling hepatic bile acid synthesis. Modulating bile acid synthesis greatly impacts in metabolism, because these receptors also are implicated in glucose, lipid, and energy expenditure. Recent studies had revealed the way these receptors participate in regulating gluconeogenesis, peripheral insulin sensitivity, glycogen synthesis, glucagon like peptide 1 (GLP-1) and insulin secretion. Nowadays, it is demonstrated that enhancing bile acid signaling in the intestine contributes to the metabolic benefits of bile acid sequestrants and bariatric surgery on glucose homeos-tasis. This paper discusses the role of bile acid as regulators of glucose metabolism and their potential as therapeutic targets for diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The GM influences BA metabolism, and BAs affect the GM’s composition (296).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [296]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Identification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 974
Cited by
Sorted by citations
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota
Beam, A., Clinger, E., & Hao, L. (2021) · Nutrients · doi:10.3390/nu13082795 · Cited by 576
Bile Acids Activated Receptors Regulate Innate Immunity
Fiorucci, S., Biagioli, M., Zampella, A., & Distrutti, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01853 · Cited by 580
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Masoodi, M., Gastaldelli, A., Hyötyläinen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00502-9 · Cited by 451
Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis
Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130689 · Cited by 415
You Are What You Eat—The Relationship between Diet, Microbiota, and Metabolic Disorders—A Review
Moszak, M., Szulińska, M., & Bogdański, P. (2020) · Nutrients · doi:10.3390/nu12041096 · Cited by 397
Unraveling the regulation of hepatic gluconeogenesis
Zhang, X., Yang, S., Chen, J., & Su, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00802 · Cited by 314
Alterations of Bile Acids and Gut Microbiota in Obesity Induced by High Fat Diet in Rat Model
Lin, H., An, Y., Tang, H., & Wang, Y. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b00249 · Cited by 240
Konopelski, P., & Mogilnicka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031222 · Cited by 220
Wang, S., Yu, Y., & Adeli, K. (2020) · Microorganisms · doi:10.3390/microorganisms8040527 · Cited by 216
Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes
Jyoti, & Dey, P. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00066-1 · Cited by 229
Diet and microbiota linked in health and disease
Requena, T., Martínez‐Cuesta, M. C., & Peláez, C. (2018) · Food & Function · doi:10.1039/c7fo01820g · Cited by 191
Hughes, R., & Holscher, H. D. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab077 · Cited by 212
New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
Méndez‐Sánchez, N., Cruz-Ramón, V., Ramírez-Pérez, O., Hwang, J. P., Barranco-Fragoso, B., & Córdova‐Gallardo, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072034 · Cited by 177
Role of gut microbiota in identification of novel TCM-derived active metabolites
Lin, T., Lu, C., Lai, W.-F., Wu, T., Lu, J., Chen, Y.-M., Tzeng, C., Liu, H., Wei, H., & Lai, H. (2020) · Protein & Cell · doi:10.1007/s13238-020-00784-w · Cited by 175
Kandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R. K., Bala, K., Sonawane, A., & Jha, H. C. (2022) · Metabolites · doi:10.3390/metabo12111064 · Cited by 177
Tang, X., Wang, W., Hong, G., Duan, C., Zhu, S., Tian, Y., Han, C., Qian, W., Lin, R., & Hou, X. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00711-z · Cited by 159
Sipos, A., Ujlaki, G., Mikó, E., Maka, E., Szabó, J., Uray, K., Krasznai, Z. T., & Bai, P. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00295-2 · Cited by 153
Low-Grade Chronic Inflammation: a Shared Mechanism for Chronic Diseases
Cifuentes, M., Verdejo, H., Castro, P., Corvalán, A. H., Catterina Ferreccio, R., Quest, A. F. G., Kogan, M. J., & Lavandero, S. (2024) · Physiology · doi:10.1152/physiol.00021.2024 · Cited by 167
Gallstone Disease and Microbiome
Григорьева, И. Н., & Романова, Т. И. (2020) · Microorganisms · doi:10.3390/microorganisms8060835 · Cited by 144
Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke
Wu, H., & Chiou, J. A. (2021) · Nutrients · doi:10.3390/nu13082878 · Cited by 153
Cheng, H., Liu, J., Tan, Y., Feng, W., & Peng, C. Y. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.10.003 · Cited by 140
Tripathi, A., Melnik, A. V., Xue, J., Poulsen, O., Meehan, M. J., Humphrey, G., Jiang, L., Ackermann, G. L., McDonald, D. T., Zhou, D., et al. (2018) · mSystems · doi:10.1128/msystems.00020-18 · Cited by 135
Đanić, M., Stanimirov, B., Pavlović, N., Goločorbin-Kon, S., Al‐Salami, H., Stankov, K., & Mikov, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01382 · Cited by 135
Colonization and development of the gut microbiome in calves
Du, Y., Gao, Y., Hu, M., Hou, J., Yang, L., Wang, X., Du, W., Liu, J., & Xu, Q. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00856-x · Cited by 150
Swine gut microbiota and its interaction with host nutrient metabolism
Wang, H., Xu, R., Zhang, H., Su, Y., & Zhu, W. (2020) · Animal nutrition · doi:10.1016/j.aninu.2020.10.002 · Cited by 117
Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
Park, J. W., Kim, S. E., Lee, N. Y., Kim, J. H., Jung, J.-H., Jang, M.-K., Park, S.-H., Lee, M.-S., Kim, D.-J., Kim, H.-S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010426 · Cited by 110
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2018) · F1000Research · doi:10.12688/f1000research.14841.1 · Cited by 106
Linking Gut Microbiome and Lipid Metabolism: Moving beyond Associations
Lamichhane, S., Sen, P., Alves, M. A., Ribeiro, H. C., Raunioniemi, P., Hyötyläinen, T., & Orešič, M. (2021) · Metabolites · doi:10.3390/metabo11010055 · Cited by 101
Wise, J. L., & Cummings, B. P. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1093420 · Cited by 94
Gutierrez, D., Weinstock, A., Antharam, V. C., Gu, H., Jasbi, P., Shi, X., Dirks, B., Krajmalnik‐Brown, R., Maldonado, J., Guinan, J., et al. (2019) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiz187 · Cited by 102
The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus
Crăciun, C.-I., Neag, M. A., Cătinean, A., Mitre, A. O., Rusu, A., Bala, C. G., Román, G., Buzoianu, A. D., Muntean, D. M., & Craciun, A. E. (2022) · Biomedicines · doi:10.3390/biomedicines10020308 · Cited by 95
The microbiota-gut-brain axis: Focus on the fundamental communication pathways
Bistoletti, M., Bosi, A., Banfi, D., Giaroni, C., & Baj, A. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.012 · Cited by 91
Host metabolism balances microbial regulation of bile acid signalling
Won, T. H., Arifuzzaman, M., Parkhurst, C. N., Miranda, I. C., Zhang, B., Hu, E., Kashyap, S., Letourneau, J., Jin, W., Fu, Y., et al. (2025) · Nature · doi:10.1038/s41586-024-08379-9 · Cited by 100
The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy
Aarnoutse, R., Ziemons, J., Penders, J., Rensen, S. S., de Vos‐Geelen, J., & Smidt, M. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174145 · Cited by 84
Epigenetic effects of short-chain fatty acids from the large intestine on host cells
Stein, R. A., & Riber, L. (2023) · microLife · doi:10.1093/femsml/uqad032 · Cited by 85
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Zhang, Y., Li, Z.-J., Gou, H.-Z., Song, X., & Zhang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945368 · Cited by 77
Pezzino, S., Sofia, M., Faletra, G., Mazzone, C., Litrico, G., Greca, G. L., & Latteri, S. (2022) · Biology · doi:10.3390/biology11111622 · Cited by 77
Effect of Gut Microbiota on Blood Cholesterol: A Review on Mechanisms
Deng, C., Pan, J., Zhu, H., & Chen, Z. (2023) · Foods · doi:10.3390/foods12234308 · Cited by 70
Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders
Simpson, S., Mclellan, R., Wellmeyer, E., Matalon, F., & George, O. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10022-7 · Cited by 63
Gut Microbiota Modulates Interactions Between Polychlorinated Biphenyls and Bile Acid Homeostasis
Cheng, S. L., Li, X., Lehmler, H., Phillips, B., Shen, D. D., & Cui, J. Y. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy208 · Cited by 58
The contribution of age-related changes in the gut-brain axis to neurological disorders
Khan, R., Gesù, C. M. D., Lee, J., & McCullough, L. D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2302801 · Cited by 62
Pectin mediates the mechanism of host blood glucose regulation through intestinal flora
Guo, Q., Hou, X., Cui, Q., Li, S., Shen, G., Luo, Q., Wu, H., Chen, H., Liu, Y., Chen, A., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2173719 · Cited by 63
Unveiling roles of beneficial gut bacteria and optimal diets for health
Kumar, S., Mukherjee, R., Gaur, P., Leal, E. D. S., Lyu, X., Ahmad, S., Puri, P., Chang, C.-M., Raj, V. S., & Pandey, R. P. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1527755 · Cited by 63
The gut microbiota–bile acid–TGR5 axis orchestrates platelet activation and atherothrombosis
Qi, Z., Zhang, W., Zhang, P., Qu, Y., Zhong, H., Zhou, L., Zhou, W., Yang, W., Xu, H., Zhao, X., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00637-x · Cited by 65
Dysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes
Lamichhane, S., Sen, P., Dickens, A. M., Alves, M. A., Härkönen, T., Honkanen, J. K., Vatanen, T., Xavier, R. J., Hyötyläinen, T., Knip, M., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100762 · Cited by 58
The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis
Cheon, S. Y., & Song, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010463 · Cited by 56
Luo, M., Yan, J., Wu, L., Wu, J., Chen, Z., Jiang, J., Chen, Z., & He, B. (2021) · Journal of Immunology Research · doi:10.1155/2021/2264737 · Cited by 52
Wang, T., Wang, X., Lee‐Sarwar, K. A., Litonjua, A. A., Weiss, S. T., Sun, Y., Maslov, S., & Liu, Y. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00627-3 · Cited by 55
Plant-sourced intrinsic dietary fiber: Physical structure and health function
Qin, W., Sun, L., Miao, M., & Zhang, G. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.09.022 · Cited by 53
Ocansey, D. K. W., Zhang, Z., Xu, X., Liu, L., Amoah, S., Chen, X., Wang, B., Zhang, X., & Mao, F. (2022) · Biomaterials Science · doi:10.1039/d2bm00559j · Cited by 51
The intestinal microbiome associated with lipid metabolism and obesity in humans and animals
Jian, Z., Zeng, L., Xu, T., Sun, S., Yan, S., Zhao, S., Su, Z., Ge, C., Zhang, Y., Jia, J., et al. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15740 · Cited by 55
Kupikowska-Stobba, B., Niu, H., Klojdová, I., Agregán, R., Lorenzo, J. M., & Kasprzak, M. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.142151 · Cited by 57
Binda, C., Gibiino, G., Coluccio, C., Sbrancia, M., Dajti, E., Sinagra, E., Capurso, G., Sambri, V., Cucchetti, A., Ercolani, G., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10020312 · Cited by 52
Tissue-wide metabolomics reveals wide impact of gut microbiota on mice metabolite composition
Zarei, I., Koistinen, V., Kokla, M., Klåvus, A., Babu, A. F., Lehtonen, M., Auriola, S. O. K., & Hanhineva, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-19327-w · Cited by 49
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity
Biagioli, M., & Carino, A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_225 · Cited by 51
Xia, F., Wen, L., Ge, B., Li, Y., Li, F., & Zhou, B. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i8.1146 · Cited by 55
Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155254 · Cited by 49
Bile Acids in Hepatic Encephalopathy
DeMorrow, S. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.04.011 · Cited by 48
Liu, X., Zheng, H., Lu, R., Huang, H., Zhu, H., Yin, C., Mo, Y.-Y., Wu, J., Liu, X., Deng, M., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01151 · Cited by 48
Fatty acid metabolism and acyl-CoA synthetases in the liver-gut axis
Ma, Y., Nenkov, M., Chen, Y., Press, A. T., Kaemmerer, E., & Gaßler, N. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i11.1512 · Cited by 49
Lean nonalcoholic fatty liver disease and sarcopenia
Chen, M., Cao, Y. Y., Ji, G., & Zhang, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217249 · Cited by 47
Lin, X., Xia, L., Zhou, Y., Xie, J., Tuo, Q., Lin, L., & Liao, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094240 · Cited by 48
Probiotics as a therapeutic strategy in obesity and overweight: a systematic review
Tomé-Castro, X. M., Rodríguez-Arrastia, M. J., Cardona, D., Rueda‐Ruzafa, L., Molina‐Torres, G., & Román, P. (2021) · Beneficial Microbes · doi:10.3920/bm2020.0111 · Cited by 43
The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy
Zhang, H., & Mo, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1205846 · Cited by 42
Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
Shi, Q., Yuan, X., Zeng, Y., Wang, J., Zhang, Y., Chen, X., & Li, L. (2023) · Nutrients · doi:10.3390/nu15102411 · Cited by 41
Lung cancer metabolomics: a pooled analysis in the Cancer Prevention Studies
Tang, Z., Liang, D., Deubler, E. L., Sarnat, J. A., Chow, S. S., Diver, W. R., & Wang, Y. (2024) · BMC Medicine · doi:10.1186/s12916-024-03473-1 · Cited by 40
Zhang, F., Yuan, W., Wei, Y., Zhang, D., Duan, Y., Li, B., Wang, X., Xi, L., Zhou, Y., & Wu, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.031 · Cited by 40
Gupta, B., Liu, Y., Chopyk, D. M., Rai, R. P., Desai, C., Kumar, P., Farris, A. B., Nusrat, A., Parkos, C. A., Anania, F. A., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902687r · Cited by 41
Phenolic Compounds Present in Yerba Mate Potentially Increase Human Health: A Critical Review
de Vasconcellos, A. C., Jeverson Frazzon, B., & Noreña, C. P. Z. (2022) · Plant Foods for Human Nutrition · doi:10.1007/s11130-022-01008-8 · Cited by 40
Kriss, M. S., Verna, E. C., Rosen, H. R., & Lozupone, C. (2018) · Transplantation · doi:10.1097/tp.0000000000002568 · Cited by 37
Metaflammation’s Role in Systemic Dysfunction in Obesity: A Comprehensive Review
Crasan, I.-M., Tanase, M., Delia, C., Pîrcălăbioru, G. G., Cîmpean, A., & Ionica, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110445 · Cited by 42
Rogala, A. R., Oka, A., & Sartor, R. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00214 · Cited by 35
Wellhöner, F., Döscher, N., Woelfl, F., Vital, M., Plumeier, I., Kahl, S., Potthoff, A., Manns, M. P., Pieper, D. H., Cornberg, M., et al. (2021) · Hepatology · doi:10.1002/hep.31700 · Cited by 35
Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids
Way, G. W., Jackson, K. G., Muscu, S., & Zhou, H. (2022) · Cells · doi:10.3390/cells11081374 · Cited by 36
In Vitro Replication of Human Norovirus
Bhar, S., & Jones, M. K. (2019) · Viruses · doi:10.3390/v11060547 · Cited by 36
Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment
Filipović, B. F., Marjanovic-Haljilji, M., Mijac, D. D., Lukić, S., Kapor, S., Kapor, S., Starčević, A., Popovic, D. D., & Djoković, A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110573 · Cited by 34
Microbial metabolites: cause or consequence in gastrointestinal disease?
Fobofou, S. A. T., & Savidge, T. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00008.2022 · Cited by 36
[Retracted] A Review of Bile Acid Metabolism and Signaling in Cognitive Dysfunction‐Related Diseases
Weng, Z.-B., Chen, Y.-R., Lv, J.-T., Wang, M.-X., Chen, Z.-Y., Zhou, W., Shen, X.-C., Zhan, L.-B., & Wang, F. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4289383 · Cited by 32
“C C Changes in gut micro fl ora also alter the expression level of BSH, thus a ff ecting the composition of the host BA pool and BA signaling [10, 25] (more details are shown in Figure 1).”
RetractedXia, J., Tang, N., Wu, X., & Ren, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1033145 · Cited by 32
Bile acids and microbes in metabolic disease
Sah, D. K., Arjunan, A., Park, S. Y., & Jung, Y. D. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i48.6846 · Cited by 34
Role of bile acids in overweight and obese children and adolescents
Giannini, C., Mastromauro, C., Scapaticci, S., Gentile, C., & Chiarelli, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1011994 · Cited by 32
A critical review of bile acids and their receptors in hepatic encephalopathy
Williams, E., Chu, C. S., & DeMorrow, S. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114436 · Cited by 34
Gut microbiota alterations in response to sleep length among African-origin adults
Fei, N., Choo-Kang, C., Reutrakul, S., Crowley, S. J., Rae, D. E., Bedu-Addo, K., Plange‐Rhule, J., Forrester, T., Lambert, E. V., Bovet, P., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255323 · Cited by 31
Du, Z., Zhou, X., Zhao, J., Bi, J., Ren, Y., Zhang, J., Lin, Y., Wu, Z., Lv, Y., Zhang, X., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4855-9 · Cited by 29
Kanmani, S., Son, T., Kim, K., & Koo, B. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104583 · Cited by 31
The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes
Zheng, Y., Ran, Y., Zhang, H., Wang, B., & Zhou, L. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.715852 · Cited by 29
Characterization of Gut Microbiota Composition in Type 2 Diabetes Patients: A Population-Based Study
Polidori, I., Marullo, L., Ialongo, C., Tomassetti, F., Colombo, R., Gaudio, F. D., Calugi, G., Marrone, G., Noce, A., Bernardini, S., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315913 · Cited by 29
Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
Kouhzad, M., Götz, F., Navidifar, T., Taki, E., Ghamari, M., Mohammadzadeh, R., Seyedolmohadesin, M., & Bostanghadiri, N. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1514872 · Cited by 31
Significance of African Diets in Biotherapeutic Modulation of the Gut Microbiome
Isibor, P. O., Akinduti, P. A., Aworunse, O. S., Oyewale, J., Oshamika, O. O., Ugboko, H. U., Taiwo, O., Ahuekwe, E. F., Obafemi, Y. D., Onibokun, E. A., et al. (2021) · Bioinformatics and Biology Insights · doi:10.1177/11779322211012697 · Cited by 30
Tris(1,3-dichloro-2-propyl) phosphate is a metabolism-disrupting chemical in male mice
Tenlep, S. Y. N., Weaver, M. L., Chen, J., Vsevolozhskaya, O. A., Morris, A. J., & Rashid, C. S. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.11.021 · Cited by 27
Xu, Z., Zhou, Y., Xie, R., & Ning, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1624878 · Cited by 28
Chen, Y., & Wang, M. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s334325 · Cited by 25
Thangamani, S., Monasky, R. C., Lee, J. K., Antharam, V. C., HogenEsch, H., Hazbun, T. R., Jin, Y., Gu, H., & Guo, G. L. (2021) · Journal of Fungi · doi:10.3390/jof7121030 · Cited by 24
Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers
Pallozzi, M., Gaetano, V. D., Tommaso, N. D., Cerrito, L., Santopaolo, F., Stella, L., Gasbarrini, A., & Ponziani, F. R. (2024) · Nutrients · doi:10.3390/nu16142372 · Cited by 23
Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development
Rodríguez‐Antonio, I., López-Sánchez, G. N., Garrido-Camacho, V. Y., Uribe, M., Chávez-Tapia, N. C., & Nuño‐Lámbarri, N. (2020) · HPB · doi:10.1016/j.hpb.2020.07.011 · Cited by 23
Self-citationRoles of bile acids in enteric virus replication
Kong, F., Saif, L. J., & Wang, Q. (2021) · Animal Diseases · doi:10.1186/s44149-021-00003-x · Cited by 25
Gupta, B., Rai, R. P., Oertel, M., & Raeman, R. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1748037 · Cited by 24
Farnesoid X receptor: An important factor in blood glucose regulation
Hou, Y., Fan, W., Yang, W., Samdani, A. Q., Jackson, A. O., & Qu, S.-L. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.03.1626 · Cited by 23
Hou, K., Zhang, S., Wu, Z., Zhu, D., Chen, F., Lei, Z.-N., Liu, W., Xiao, C., & Chen, Z.-S. (2021) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.6323 · Cited by 24
Kiriyama, Y., & Nochi, H. (2023) · Genes · doi:10.3390/genes14040825 · Cited by 22
Metadata
- Authors
- Alberto González-Regueiro, J., Moreno-Castañeda, L., Uribe, M., & Carlos Chávez-Tapia, N.
- Affiliations
- Hospital Médica Sur (MX)
- ORCID
- Uribe, Misael
- Venue
- Annals of Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 16
- Issue
- Suppl. 1: s3-105.
- Pages
- S15-S20
- ISSN
- 1665-2681 (ISSN-L)
- OpenAlex
- W3194266802
- Cited by
- 247
- References
- 49
- Citations by year
- 2026: 25 · 2025: 26 · 2024: 43 · 2023: 34 · 2022: 34 · 2021: 38 · 2020: 20 · 2019: 12 · 2018: 15
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Annals of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Australian Government
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- bile acids, glucose metabolism, diabetes mellitus, enterohepatic circulation, farnesoid X receptor, TGR5, bile acid synthesis, gluconeogenesis, insulin sensitivity, glycogen synthesis, glucagon-like peptide-1, insulin secretion, bile acid sequestrants, bariatric surgery, glucose homeostasis, therapeutic target
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Bile Acids and Salts, Energy Metabolism, Humans, Intestines, Obesity, Signal Transduction, Host-Pathogen Interactions, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review